GL1X · GenesisL1 explorer

MolNFT v1 · #40978 · protein

Atomic-resolution crystal structure of chemically-synthesized HIV-1 protease complexed with inhibitor mvt-101

2J9K: “Atomic-resolution crystal structure of chemically-synthesized HIV-1 protease complexed with inhibitor mvt-101”. X-ray diffraction, 2 ligands (2NC, SO4), 1 pocket (best druggability 0.70). MolNFT v1 #40978 on GenesisL1: 3D structure…

PDB
2J9K
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease
UniProt
O38907
Ligands
2NC, SO4
Pockets
1 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 55% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProteaseprotein994% helix, 55% strandO38907

Ligands and binding sites

  • 2NC · N-{(2S)-2-[(N-acetyl-L-threonyl-L-isoleucyl)amino]hexyl}-L-norleucyl-L-glutaminyl-N~5~-[amino(iminio)methyl]-L-ornithinamide · ligand · chains A, B
  • SO4 · Sulfate ion · ion · 5 copies · chains A, B
  • ACT · Acetate ion · additive · 5 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13690.700.82352NC

Interfaces

1 interface between chains.

  • A–B · 1839 Ų buried · 38 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 10 modified (nonstandard).

Compared structures

  • 2J9K · Atomic-resolution Crystal Structure of Chemically-Synthesized HIV-1 Protease Complexed… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.